News from the fight to
#SaveIndependentPharmacy
New York Times The Middlemen series
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients.
Legalized Racketeering? How PBMs Skirt the Law to Rake in Billions
Pharmacy Benefit Managers (PBMs) have been under scrutiny lately for their actions as middlemen in the flow of prescription drugs from manufacturers to patients. But perhaps their worst actions are buried within a maze of consolidation and paperwork. Big Insurance has consolidated the entire pharmaceutical benefit, claim, and dispensing sector to squeeze as much money out of patients as possible.
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices
Caremark, Express Scripts, Optum, and their affiliates created a broken rebate system that inflated insulin drug prices, boosting PBM profits at the expense of vulnerable patients, the FTC alleges.
Why Walgreens And CVS Are Shutting Down Thousands Of Stores
In its fiscal third-quarter report, Walgreens announced its plans to close a ‘significant’ amount of stores, acknowledging only 75% of its 8,600 stores were profitable. While no specific stores were tapped for closure yet, more than 2,000 locations could face the chopping block by 2027. This just the latest sign of trouble for the struggling retail pharmacy sector as CVS and Rite Aid both announced large closures in the past year. Watch the video to learn why U.S. pharmacy chains are fighting for survival.
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
Pharmacy Benefit Managers (PBMs) are driving up drug costs for millions of people, employers and the government.
The second in “THE MIDDLEMEN” series of articles by reporters Rebecca Robins and Reed Abelson investigating PBMs.
CVS hellth: Corporate consolidation is ruining pharmacies and hurting patients
An opinion piece by pharmacist and independent pharmacy advocate Luke Slindee.
Commerce fines CVS Caremark $500,000 after 2022 case alleging violations of Pharmacy Benefit Manager Act
The Minnesota Department of Commerce announced it has levied a $500,000 penalty against the pharmacy benefit manager CVS Caremark after alleging that Caremark violated state law prohibiting a practice known as ‘patient steering.’
The biggest Pharmacy Benefit Managers (PBMs) are profiting by systematically underpaying independent drugstores, creating “pharmacy deserts” across the country.
The third in “THE MIDDLEMEN” series of articles by reporters Rebecca Robins and Reed Abelson investigating PBMs .